Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:24:41.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a restricted-access notice; the visible area shows a simple header and footer with the error message.
    Difference
    20%
    Check dated 2026-09-21T19:53:54.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new page revision tag, v3.6.6, has been added and the previous tag, v3.6.5, removed. This reflects a minor update to the page’s versioning or formatting.
    Difference
    0.1%
    Check dated 2026-08-31T16:46:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page adds footer-level metadata and regulatory context, including FDA-regulated notices, IPD planning, PubMed publications, and related topic links, enhancing access to regulatory information and related resources without altering the study details.
    Difference
    56%
    Check dated 2026-08-17T12:21:01.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.5, indicating a minor update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-08-10T07:39:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a minor template or platform update with no changes to the study details or user interactions.
    Difference
    0.1%
    Check dated 2026-07-26T19:20:40.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.